Post-Polio Syndrome: Clinical Trials

3 completed, 1 terminated. 4 Phase 3, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	4	Completed 3, Terminated 1
Phase 2	2	Completed 1, Terminated 1

Follow Post-Polio Syndrome: new trials by email Literature Review of Post-Polio Syndrome trials Research Report on Post-Polio Syndrome

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
L-Citrulline in Patients With Post-Polio Syndrome 15g L-citrulline daily p.o., Placebo - Post-Polio Syndrome	Phase 3	Completed	Dirk Fischer	30	2016-06-14	2019-01-23
Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome Flebogamma® 5% DIF, Placebo - Post-polio Syndrome	Phase 2 / Phase 3	Terminated	Instituto Grifols, S.A.	191	2014-09-23	2025-12-05
Intravenous Immunoglobulins for Post-Polio Syndrome intravenous immunoglobulins, Saline solution - Post-polio Syndrome	Phase 3	Completed	Azienda Ospedaliera Universitaria Integrata Verona	50	2008-01-01	2012-02-27
Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg) IvIg - Post-Polio Syndrome	Phase 2 / Phase 3	Completed	Haukeland University Hospital	40	2003-08-01	2005-12-13

Narrower conditions

Postpoliomyelitis Syndrome (4)

Broader conditions

Central Nervous System Diseases (4)  ·  Central Nervous System Infections (4)  ·  Enterovirus Infections (4)  ·  Infections (4)  ·  Muscular Diseases (4)  ·  Muscular Disorders, Atrophic (4)  ·  Musculoskeletal Diseases (4)  ·  Myelitis (4)  ·  Nervous System Diseases (4)  ·  Neurodegenerative Diseases (4)  ·  Neuroinflammatory Diseases (4)  ·  Neuromuscular Diseases (4)  ·  Picornaviridae Infections (4)  ·  Poliomyelitis (4)  ·  RNA Virus Infections (4)

Interventions

Immunoglobulins, Intravenous (3)  ·  Saline Solution (1)  ·  gamma-Globulins (1)

Sponsors

Azienda Ospedaliera Universitaria Integrata Verona (1)  ·  Dirk Fischer (1)  ·  Haukeland University Hospital (1)  ·  Instituto Grifols, S.A. (1)

Countries

Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Dirk Fischer, Prof. (1)  ·  Elisabeth Farbu, MD, PhD (1)  ·  Marinos Dalakas, MD (1)

Results publications

PMID 28274276, PMID 32676980